Tech-First Companies Take the Lead in AI Drug Discovery
Biopharmaceutical Report II Issue27_August 2023 In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has...
Tech-First Companies Take the Lead in AI Drug Discovery
Companies Making Automated Drug Discovery A Reality
Artificial Intelligence in Drug Discovery and Biotech; 2022 Recap and Key Trends
17 Companies Building the Future of Drug Development on a Chip
Innovative Value-Based Price Programs Back in the Spotlight
Upper Middle-Income Countries Left Out by New Merck/Ridgeback COVID-19 Antiviral Licensing Deal
Medicare's National Coverage Determination Could Boost Chances of Limited Aduhelm Coverage
Pepaxto's US Uptake to Stall in Multiple Myeloma Until FBA Provides Advice to Address Death Risk
Innovations Forged in the COVID Crucible Will Reshape Medicine
COVID-19 Long-Hauler Treatments Could Employ Repurposed Trial Endpoints to Prove Aptitude